Stay updated with breaking news from Klingenstein Fields. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
J2 Capital Management Inc grew its position in shares of SPDR Gold Shares (NYSEARCA:GLD – Get Rating) by 103.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,367 shares of the exchange traded fund’s stock after buying an additional 3,745 […]
Klingenstein Fields & Co. LP lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) by 1.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 275,998 shares of the company’s stock after selling 5,095 shares during the period. Johnson & Johnson accounts for about 2.5% of Klingenstein Fields & Co. LP’s […]
Klingenstein Fields & Co. LP trimmed its stake in shares of Alphabet Inc. (NASDAQ:GOOG – Get Rating) by 2.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 232,580 shares of the information services provider’s stock after selling 5,333 shares during the […]
Kades & Cheifetz LLC acquired a new position in Schwab Emerging Markets Equity ETF (NYSEARCA:SCHE – Get Rating) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 45,861 shares of the company’s stock, valued at approximately $1,086,000. Several other institutional investors also recently modified […]
Klingenstein Fields & Co. LP trimmed its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Get Rating) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 323,552 shares of the company’s stock after selling 7,702 shares during the period. Merck & Co., […]